Hospital
National Jewish Health
National Jewish Health was paid $7.68M by Medicaid between Jan 2018 and Nov 2024, across 125 billing codes. Its largest line is 95811, — 26% of everything it billed.
33Billing provider infoNATIONAL JEWISH HEALTH
DENVER, CO 80206
DENVER, CO 80206
33aNPI1326015777assigned 03/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.68M
24GClaims164,934
24DCodes billed125
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#18 of 51
Median peer was paid$1.24M
This provider vs. median6.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,868 | $2.42M | |
| 2019 | 43,489 | $2.16M | |
| 2020 | 23,259 | $1.41M | |
| 2021 | 13,015 | $668K | |
| 2022 | 10,820 | $349K | |
| 2023 | 14,285 | $423K | |
| 2024incomplete | 12,198 | $252K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95811 | 26% | 4,637 | 2,599 | $2.01M | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 38,914 | 24,164 | $1.18M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 8.2% | 1,550 | 805 | $631K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 6.1% | 2,136 | 1,244 | $466K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 5.0% | 2,966 | 1,229 | $381K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4.7% | 6,254 | 3,538 | $359K |
| 94375 | 3.8% | 5,065 | 4,156 | $293K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.0% | 2,707 | 2,200 | $233K |
| 88342 | 2.3% | 3,500 | 2,104 | $178K | |
| 80053 | Comprehensive metabolic panel | 2.3% | 9,171 | 8,102 | $175K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.2% | 3,505 | 1,464 | $165K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2.1% | 390 | 245 | $165K |
113 more codes
| 99205 | Prolong outpt/office vis | 1.6% | 2,034 | $124K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.6% | 6,064 | $120K |
| 86140 | 1.5% | 7,806 | $114K | |
| 31231 | 1.5% | 842 | $113K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.4% | 2,079 | $107K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 14,596 | $90K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.1% | 2,598 | $84K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.0% | 2,140 | $78K |
| J2357 | Injection, omalizumab, 5 mg | <1% | 85 | $65K |
| 95806 | <1% | 272 | $56K | |
| 71250 | <1% | 1,803 | $46K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,420 | $40K |
| 94664 | <1% | 425 | $32K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 130 | $32K |
| 85652 | <1% | 7,210 | $27K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 381 | $26K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,255 | $25K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,201 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 312 | $14K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,877 | $13K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,221 | $12K |
| 83880 | <1% | 538 | $10K | |
| 80061 | Lipid panel | <1% | 672 | $10K |
| 94060 | <1% | 483 | $9K | |
| 86160 | <1% | 683 | $9K | |
| 86235 | <1% | 381 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,126 | $8K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 31 | $8K |
| 94618 | <1% | 63 | $7K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 162 | $7K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 69 | $7K |
| 83516 | <1% | 382 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,099 | $6K |
| 73130 | <1% | 287 | $5K | |
| 81001 | <1% | 95 | $5K | |
| 95012 | <1% | 106 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 708 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 62 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 41 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $4K |
| 86328 | <1% | 93 | $4K | |
| 94726 | <1% | 63 | $4K | |
| 95117 | <1% | 140 | $3K | |
| 86225 | <1% | 459 | $3K | |
| 94010 | <1% | 58 | $3K | |
| 99223 | Prolong inpt eval add15 m | <1% | 32 | $3K |
| 88341 | <1% | 43 | $3K | |
| 82728 | <1% | 265 | $3K | |
| 93299 | <1% | 144 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 77 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 67 | $2K |
| 84439 | <1% | 605 | $2K | |
| 73630 | <1% | 129 | $2K | |
| 86703 | <1% | 74 | $2K | |
| 81003 | <1% | 113 | $2K | |
| 82784 | <1% | 130 | $2K | |
| 95800 | <1% | 14 | $2K | |
| 86803 | <1% | 235 | $2K | |
| 86705 | <1% | 74 | $2K | |
| 86431 | <1% | 193 | $2K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 150 | $2K |
| 84156 | <1% | 135 | $1K | |
| 86704 | <1% | 118 | $1K | |
| 82550 | <1% | 245 | $1K | |
| 87340 | <1% | 123 | $1K | |
| 83540 | <1% | 401 | $1K | |
| 82785 | <1% | 27 | $1K | |
| 83550 | <1% | 402 | $1K | |
| 86038 | <1% | 168 | $1K | |
| 83735 | <1% | 468 | $1K | |
| 82607 | <1% | 186 | $1K | |
| 86481 | <1% | 56 | $1K | |
| 94729 | <1% | 74 | $971.82 | |
| 93296 | <1% | 69 | $896.02 | |
| 82570 | <1% | 149 | $802.25 | |
| 96152 | <1% | 235 | $716.00 | |
| 85610 | <1% | 198 | $715.21 | |
| 85027 | <1% | 67 | $697.08 | |
| 93298 | <1% | 49 | $485.70 | |
| 87116 | <1% | 33 | $444.08 | |
| 86812 | <1% | 14 | $442.96 | |
| 83704 | <1% | 43 | $412.02 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 19 | $411.17 |
| 84182 | <1% | 65 | $406.25 | |
| 82172 | <1% | 43 | $305.50 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 18 | $301.12 |
| 86706 | <1% | 32 | $293.60 | |
| 84165 | <1% | 60 | $290.79 | |
| 93018 | <1% | 25 | $275.80 | |
| 84432 | <1% | 12 | $269.76 | |
| 87102 | <1% | 49 | $232.13 | |
| 86146 | <1% | 12 | $216.45 | |
| 83695 | <1% | 58 | $203.24 | |
| 36592 | <1% | 65 | $176.10 | |
| 86376 | <1% | 29 | $175.66 | |
| 86147 | <1% | 12 | $172.07 | |
| 94760 | <1% | 4,589 | $153.70 | |
| 86800 | <1% | 12 | $134.88 | |
| 87077 | <1% | 31 | $119.08 | |
| 86364 | <1% | 13 | $100.81 | |
| 87205 | <1% | 48 | $90.20 | |
| 87071 | <1% | 48 | $88.16 | |
| 87015 | <1% | 33 | $75.91 | |
| 82085 | <1% | 13 | $57.30 | |
| 80076 | <1% | 12 | $56.52 | |
| 87206 | <1% | 33 | $50.05 | |
| 82043 | <1% | 14 | $19.68 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 591 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 536 | $0.00 |
| 36416 | 0% | 40 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 420 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 23 | $0.00 |
| 85008 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSALEM, MICHAEL (PRESIDENT/CEO)